Arkolith/Insider Trading/AMLX/Form 4

Mazzariello Gina

Chief Legal OfficerAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed Feb 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Sell(S)4K$3.15$13K135K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-027833) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML